CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Dual-Energy Contrast-Enhanced (DECE) mammography +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02995980
NCT02995980N/ACompleted

Pilot Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography to Detect Breast Cancer in Patients With Increased Breast Density (Breast Imaging-Reporting And Data System (BI-RADS) Category c or d)

University of Alabama at Birmingham·interventional·Posted Dec 19, 2016·Updated Sep 25, 2019

In Brief

A clinical study evaluating Dual-Energy Contrast-Enhanced (DECE) mammography and digital mammography for Breast Cancer. Completed, enrolled 128 participants across 1 site.

Detailed Summary

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 19, 2016
Enrollment StartNov 1, 2015
Primary CompletionMay 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.5 years ago

Interventions

Dual-Energy Contrast-Enhanced (DECE) mammographydevice

Contrast mammography

digital mammographydevice

routine digital mammography